Literature DB >> 16769913

Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival.

Konstantinos Dimopoulos1, Darlington O Okonko, Gerhard-Paul Diller, Craig S Broberg, Tushar V Salukhe, Sonya V Babu-Narayan, Wei Li, Anselm Uebing, Stephanie Bayne, Roland Wensel, Massimo F Piepoli, Philip A Poole-Wilson, Darrel P Francis, Michael A Gatzoulis.   

Abstract

BACKGROUND: Limited data exist with which to stratify risk in adult congenital heart disease (ACHD). An increased ventilatory response to exercise, expressed as ventilation per unit of carbon dioxide production (V(E)/V(CO2) slope), is an established predictor of impaired survival in acquired heart disease. We sought to establish the distribution, relation to cyanosis, and prognostic value of the V(E)/V(CO2) slope across a wide spectrum of ACHD patients. METHODS AND
RESULTS: Five hundred sixty ACHD patients of varying diagnoses and 50 healthy controls underwent cardiopulmonary exercise testing at a single laboratory between 2001 and 2004. Patient age was 33.2 +/- 12.9 years (mean +/- SD). Peak oxygen consumption was 23.5 +/- 9.0 mL.kg(-1).min(-1).V(E)/V(CO2) slope for all patients was 36.3 +/-15.3. The slope was raised in all ACHD groups compared with controls and was 73% higher in cyanotic patients. Cyanosis, with or without pulmonary arterial hypertension, was the strongest predictor of abnormal V(E)/V(CO2) slope. The V(E)/V(CO2) slope was the most powerful univariate predictor of mortality in the noncyanotic group and the only independent predictor of mortality among exercise parameters on multivariate analysis. In cyanotic patients, no parameter was predictive of death.
CONCLUSIONS: Ventilatory response to exercise is abnormal across the spectrum of ACHD. Cyanosis is a powerful stimulus for such exaggerated ventilatory patterns irrespective of the presence of pulmonary arterial hypertension. Increased V(E)/V(CO2) slope is the strongest exercise predictor of death in noncyanotic ACHD patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16769913     DOI: 10.1161/CIRCULATIONAHA.105.594218

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  34 in total

1.  Pulmonary function in children after surgical and percutaneous closure of atrial septal defect.

Authors:  Mahmoud Zaqout; Frans De Baets; Petra Schelstraete; Bert Suys; Joseph Panzer; Katrien Francois; Thierry Bove; Ilse Coomans; Daniel De Wolf
Journal:  Pediatr Cardiol       Date:  2010-08-20       Impact factor: 1.655

Review 2.  Current Management of Ebstein's Anomaly in the Adult.

Authors:  Lucy M Safi; Richard R Liberthson; Ami Bhatt
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-09

Review 3.  The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review.

Authors:  Ross Arena; Jonathan Myers; Marco Guazzi
Journal:  Heart Fail Rev       Date:  2007-11-07       Impact factor: 4.214

4.  Effect of Fontan fenestration on regional venous oxygen saturation during exercise: further insights into Fontan fenestration closure.

Authors:  Rohit S Loomba; Michael E Danduran; Jennifer E Dixon; Rohit P Rao
Journal:  Pediatr Cardiol       Date:  2013-10-23       Impact factor: 1.655

5.  Cardiopulmonary Exercise Testing for Surgical Risk Stratification in Adults with Congenital Heart Disease.

Authors:  Trevor Birkey; Jennifer Dixon; Roni Jacobsen; Salil Ginde; Melodee Nugent; Ke Yan; Pippa Simpson; Joshua Kovach
Journal:  Pediatr Cardiol       Date:  2018-06-07       Impact factor: 1.655

6.  The effect of physical activity on quality of life and serum glucose and cholesterol levels in patients with congenital heart disease.

Authors:  Efrén Martínez-Quintana; Hiurma Estupiñán-León; Liuva Déniz-Déniz; Ana Beatriz Rojas-Brito; Alejandro Barreto-Martín; Jesús María González-Martín; Guillermo Miranda-Calderín; Fayna Rodríguez-González; Antonio Tugores
Journal:  Am J Cardiovasc Dis       Date:  2021-02-15

7.  Cardiopulmonary Exercise Testing-A Valuable Tool, Not Gatekeeper When Referring Patients With Adult Congenital Heart Disease for Transplant Evaluation.

Authors:  Jonathan N Menachem; Nosheen Reza; Jeremy A Mazurek; Danielle Burstein; Edo Y Birati; Arieh Fox; Yuli Y Kim; Maria Molina; Sara L Partington; Monique Tanna; Lynda Tobin; Joyce Wald; Lee R Goldberg
Journal:  World J Pediatr Congenit Heart Surg       Date:  2019-03-04

Review 8.  The Role of Cardiopulmonary Exercise Testing for Decision Making in Patients with Repaired Tetralogy of Fallot.

Authors:  Frederic Dallaire; Rachel M Wald; Ariane Marelli
Journal:  Pediatr Cardiol       Date:  2017-06-16       Impact factor: 1.655

Review 9.  Exercise: friend or foe in adult congenital heart disease?

Authors:  Oktay Tutarel; Harald Gabriel; Gerhard-Paul Diller
Journal:  Curr Cardiol Rep       Date:  2013-11       Impact factor: 2.931

10.  Association of Albuminuria With Major Adverse Outcomes in Adults With Congenital Heart Disease: Results From the Boston Adult Congenital Heart Biobank.

Authors:  Saurabh Rajpal; Laith Alshawabkeh; Nureddin Almaddah; Caroline M Joyce; Keri Shafer; Michelle Gurvitz; Sushrut S Waikar; Finnian R Mc Causland; Michael J Landzberg; Alexander R Opotowsky
Journal:  JAMA Cardiol       Date:  2018-04-01       Impact factor: 14.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.